<DOC>
	<DOCNO>NCT00264966</DOCNO>
	<brief_summary>To determine safety efficacy multiple dos ASM8 antisense oligonucleotides asthmatic .</brief_summary>
	<brief_title>Multiple Dose ASM8 Mild Asthmatics</brief_title>
	<detailed_description>This double-blind , placebo-controlled , crossover trial evaluate safety , tolerability efficacy inhale ASM8 treatment allergen-induced asthma . Individuals stable , mild moderate allergic asthma American Thoracic Society ( ATS ) criterion ( 1 ) , history episodic wheeze shortness breath , eligible enrolment . The study divide 2 part .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Part 1 : Men woman 18 65 year age ; generally good health ; mild moderate , stable , allergic asthma define ATS criterion ( 1 ) ; history episodic wheeze shortness breath ; force expiratory volume 1 second ( FEV1 ) baseline ≥70 % predict value ; able comprehend follow require study procedure ; willing able sign inform consent form . Part 2 : Methacholine challenge baseline ( PC20 ≤16 mg/mL ) ; positive skinprick test common aeroallergens ( cat , dust mite , grass , pollen ) positive allergeninduced early late airway bronchoconstriction . Part 1 Part 2 : Significant acute chronic medical psychiatric illness ; know coagulopathy , worsen asthma respiratory infection precede 6 week ; use inhaled oral corticosteroid within last 28 day , antihistamine , immunosuppressive , nonsteroidal antiinflammatory drug , anticoagulant ( intermittent dos shortacting β2agonist allow ) ; use medication may interact ASM8 ; investigational drug use within 30 day ; clinically significant abnormality screen laboratory determination ; current tobacco use previous 3 month 10 packyears ; pregnant lactating woman ; woman actively seek pregnancy use adequate contraception ; history serious adverse effect ( SAE ) hypersensitivity drug ; 20 % decrease FEV1 FVC baseline saline methacholine challenge screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Mild asthma</keyword>
</DOC>